Declining childhood and adolescent cancer mortality-Reference-Cited by-全球学者库

Declining childhood and adolescent cancer mortality

Published:2014-05-22 Issue:16 Volume:120 Page:2497-2506
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Smith Malcolm A.¹,Altekruse Sean F.²,Adamson Peter C.³,Reaman Gregory H.⁴,Seibel Nita L.¹

Affiliation:

1. Cancer Therapy Evaluation Program; National Cancer Institute; Bethesda Maryland

2. Surveillance Research Program; National Cancer Institute; Bethesda Maryland

3. Department of Clinical Pharmacology and Therapeutics; Children's Hospital of Philadelphia; Philadelphia Pennsylvania

4. Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring Maryland

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Outcomes for children and adolescents with cancer: challenges for the 21st century;Smith;J Clin Oncol.,2010

2. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries [serial online];Pritchard-Jones;Lancet Oncol.,2013

3. National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Population Estimates Used in NCI's SEER*Stat Software http://seer.cancer.gov/popdata/methods.html 2012

4. Permutation tests for joinpoint regression with applications to cancer rates;Kim;Stat Med.,2000

5. Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trials;Stiller;Ann Oncol.,2012

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Child Health and the Pediatric Hematology-Oncology Workforce: 2020–2040;Pediatrics;2024-02-01

2. Differentiation Potential of Hypodifferentiated Subsets of Nephrogenic Rests and Its Relationship to Prognosis in Wilms Tumor;Fetal and Pediatric Pathology;2024-01-12

3. GM‐CSF, G‐CSF or no cytokine therapy with anti‐GD2 immunotherapy for high‐risk neuroblastoma;International Journal of Cancer;2023-12-18

4. Ultrasound performance in pediatric deep soft-tissue tumor characterization;Scientific Reports;2023-12-13

5. Checkpoint Immunotherapy in Pediatric Oncology: Will We Say Checkmate Soon?;Vaccines;2023-12-12